RecallDepth
Class II Terminated

Benztropine Mesylate Injection, USP, 2 mg/2 mL (1 mg/1 mL), 2 mL Single Dose Vial, Rx only, labeled as a) Manufactured for: APP Pharmaceuticals, LLC, Schaumburg, IL 60173, NDC 63323-970-02; and b) Manufactured in the USA for Nexus Pharmaceuticals Inc., Vernon Hills, IL 60061, NDC 14789-300-02

Company
Fresenius Kabi Usa, Llc
Recall Initiated
July 1, 2013
Posted
July 17, 2013
Recall Number
D-685-2013
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
65110 vials
Firm Location
Lake Zurich, IL, United States

Reason for Recall

Presence of particulate matter: characterized as thin colorless flakes that are visually and chemically consistent with glass delamination observed in reserve sample vials

Distribution

Nationwide & Puerto Rico

Lot / Code Info

a) Lot: 111412, Exp: 11/2014 b) Lots: 030712, Exp: 03/2014; 071212, Exp: 07/2014; 090512, Exp: 09/2014;

More recalls by Fresenius Kabi Usa, Llc

View all recalls by this company →

Other recent Class II Drug recalls